Vanguard Capital Management’s Vivos Therapeutics VVOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.97K Hold
60,629
– – ﹤0.01% 4022
2026
Q2
$27.6K Sell
60,629
-212,700
-78% -$167K ﹤0.01% 3989
2026
Q1
$323K Buy
+273,329
New +$438K ﹤0.01% 3740

Other funds holding VVOS

Vanguard Capital Management's VVOS Position: Q3 2026 in Review

Vanguard Capital Management held its Vivos Therapeutics (VVOS) position steady in Q3 2026 at 60,629 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #4022.

Vanguard Capital Management first reported a position in VVOS in Q1 2026 and has held it in 3 quarters since. The position peaked at $323K in Q1 2026. 27 funds tracked by Wall St. Rank hold VVOS as of Q3 2026.

  • Vanguard Capital Management held 60,629 shares of Vivos Therapeutics worth $8.97K as of Q3 2026.
  • Vanguard Capital Management left its Vivos Therapeutics share count unchanged in Q3 2026.
  • Vivos Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4022 holding.
  • Vanguard Capital Management first reported a position in Vivos Therapeutics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Vivos Therapeutics position peaked at $323K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.